WA
CME icon

Wambolt & Associates’s CME Group CME Stock Holding History

Wambolt & Associates’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,081
Closed -$228K – 222
2023
Q4 		$228K Hold
1,081
– – 0.07% 221
2023
Q3 		$216K Sell
1,081
-425
-28% -$84.5K 0.08% 225
2023
Q2 		$279K Buy
1,506
+168
+13% +$31K 0.1% 210
2023
Q1 		$255K Hold
1,338
– – 0.09% 225
2022
Q4 		$225K Sell
1,338
-210
-14% -$36.5K 0.09% 221
2022
Q3 		$274K Hold
1,548
– – 0.12% 195
2022
Q2 		$317K Sell
1,548
-3
-0.2% -$636 0.13% 184
2022
Q1 		$372K Sell
1,551
-86
-5% -$20.2K 0.14% 175
2021
Q4 		$374K Sell
1,637
-17
-1% -$3.74K 0.14% 173
2021
Q3 		$325K Hold
1,654
– – 0.13% 183
2021
Q2 		$354K Hold
1,654
– – 0.15% 178
2021
Q1 		$341K Buy
1,654
+7
+0.4% +$1.38K 0.18% 164
2020
Q4 		$300K Sell
1,647
-47
-3% -$7.99K 0.18% 163
2020
Q3 		$283K Buy
+1,694
New +$285K 0.21% 153

Other funds holding CME

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Wambolt & Associates's CME Position: Q1 2024 in Review

Wambolt & Associates sold out of CME Group (CME) in Q1 2024, closing a stake of 1,081 shares — an estimated $228K sold.

Wambolt & Associates first reported a position in CME in Q3 2020 and held it in 14 quarters. The position peaked at $374K in Q4 2021. 1,373 funds tracked by Wall St. Rank hold CME as of Q1 2024.

  • Wambolt & Associates reported no remaining CME Group position as of Q1 2024 after selling out during the quarter.
  • Wambolt & Associates sold 1,081 CME Group shares in Q1 2024, an estimated $228K.
  • Wambolt & Associates first reported a position in CME Group in Q3 2020 and held it in 14 quarters.
  • Wambolt & Associates's CME Group position peaked at $374K in Q4 2021.
  • 1,373 funds tracked by Wall St. Rank held CME Group as of Q1 2024.

Based on Wambolt & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.